
Opinion|Videos|August 6, 2026
Bringing it All Together: Final Thoughts
Finally, Zepcan and Ali reflect on the single most important lessons for pharmacists new to menin inhibitor therapy and share what they wish they'd known on day one.
Advertisement
Episodes in this series

Finally, Zepcan and Ali reflect on the single most important lessons for pharmacists new to menin inhibitor therapy and share what they wish they'd known on day one. They discuss what needs to change in current practice and offer actionable first steps pharmacists can take tomorrow to optimize their approach to therapy selection, monitoring, and patient counseling in this emerging drug class.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Oveporexton for Narcolepsy Type 1
2
Erica Schwartz Confirmed as CDC Director Amid Public Health Crises
3
Beyond the Approval: Operationalizing Zongertinib for HER2-Mutant Lung Cancer
4
KRAS-Targeted Peptide Vaccine Generates Durable Responses, Shows Promise in High-Risk Pancreatic Cancer
5


































































































